Search results for "fever"

showing 10 items of 247 documents

[Cytomegalovirus infection in immunocompetent patients. Clinical and immunological considerations].

2012

Cytomegalovirus primary infection is considered dangerous for some kinds of patients: immunocompromised (HIV-infected and transplanted patients), newborns with congenital infection, and immunocompetent patients in critical condition. CMV infection is usually asymptomatic or only mildly symptomatic in immunocompetent hosts. We collected all cases of acute CMV infection that came to our attention during the period November 2009 - May 2011 to analyze their clinical features. Immunoenzymatic methods (ELISA) were used for the detection of specific IgM and IgG antibodies in every case. We observed 73 cases of acute CMV infection. The male-female ratio was 1.5/1. The average age was 36.4. All the …

AdultMaleSettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/17 - Malattie InfettiveAdolescentFeverCytomegalovirusEnzyme-Linked Immunosorbent AssayCitomegalovirus KirDiagnosis DifferentialRisk FactorsHumansChildLymphatic DiseasesAgedRetrospective StudiesAged 80 and overInfant NewbornInfantPharyngitisMiddle AgedImmunoglobulin MChild PreschoolImmunoglobulin GCytomegalovirus InfectionsFemaleImmunocompetenceBiomarkersLe infezioni in medicina
researchProduct

[Mediterranean spotted fever in paediatric and adult patients: two clinical aspects of the same disease].

2012

Mediterranean Spotted Fever is an acute febrile disease caused by Rickettsia conorii and transmitted to humans by the brown dog tick Rhipicephalus sanguineus. Nearly 400 cases are reported every year in Sicily, mainly from June to September. The aim of this study is to compare the clinical and laboratory features of two different groups of patients , one of adults and one of children. The analysis included all adult patients with MSF diagnosed at the Institute of Infectious Diseases, Paolo Giaccone University Polyclinic in Palermo, during the period January 2007- August 2010 and all the children diagnosed with MSF at the G. Di Cristina Children Hospital in Palermo during the period January …

AdultMaleSettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/17 - Malattie InfettiveAdolescentRhipicephalus sanguineusBoutonneuse FeverPolymerase Chain ReactionDogsAnimalsHumansChildFluorescent Antibody Technique IndirectSicilyAgedRetrospective StudiesMediterranean spotted fever Rickettsia paediatricadultIncidenceInfant NewbornInfantMiddle AgedAnti-Bacterial AgentsRickettsia conoriiTreatment OutcomeChild PreschoolArachnid VectorsFemaleLe infezioni in medicina
researchProduct

Role of TLR4 Receptor Polymorphisms in Boutonneuse Fever

2005

The genetics of the interaction between host and microbes plays an essential role in the survival of the individual and attainment of longevity. The activation of toll-like receptor (TLR)4 plays a key role in natural and clonotypic immune responses. We evaluated whether TLR4 genotype is a component of genetic background protective versus rickettsiosis and whether this background influences longevity. We genotyped for +896A/G TLR4 polymorphism 78 patients affected by Boutonneuse fever, 78 age-matched controls and 78 advanced age individuals from Sicily. The +869G allele, that attenuates receptor signalling, was significantly overrepresented in patients in comparison with age-matched control…

AdultMaleSettore MED/09 - Medicina InternaGenotypemedia_common.quotation_subjectImmunologyBoutonneuse Feverpolymorphism03 medical and health sciences0302 clinical medicineGene FrequencyPolymorphism (computer science)GenotypemedicineHumansImmunology and AllergyTLR4 receptorAlleleTLR4 receptor; polymorphisms; Boutonneuse feverSicilyAllele frequencyAllelesAgedmedia_commonAged 80 and overPharmacologyPolymorphism Geneticbusiness.industryLongevityDNAMiddle Agedmedicine.diseaseToll-Like Receptor 4Boutonneuse feverRickettsiosis030220 oncology & carcinogenesisImmunologyTLR4Femalebusiness030215 immunologyInternational Journal of Immunopathology and Pharmacology
researchProduct

Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy

2020

Objectives: Alteration of smell and taste has been reported in patients with coronavirus disease 2019 (COVID-19). The incidence and clinical-symptomatic manifestation of COVID-19 is different between northern and southern Italy. This study aims to evaluate the onset of alteration of smell and taste in asymptomatic and symptomatic patients in Sicily (extreme south of Italy). Methods: This prospective cross-sectional study was performed on asymptomatic and symptomatic COVID-19 patients tested for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) from May 1 to May 15, 2020. A questionnaire was used for evaluating the prevalence of smell and taste disorders in COVID-19 patients befor…

AdultMaleTaste2019-20 coronavirus outbreakFeverCoronavirus disease 2019 (COVID-19)RhinorrheaAnosmiaAsymptomaticTaste Disorders03 medical and health sciences0302 clinical medicinemedicineHumansIn patientProspective Studies030212 general & internal medicine030223 otorhinolaryngologySicilyFatigueAgedAged 80 and overSmell DisordersSARS-CoV-2business.industryIncidenceIncidence (epidemiology)COVID-19PharyngitisMiddle AgedHospitalizationCross-Sectional StudiesDyspneaCoughItalyOtorhinolaryngologyTaste disorderCarrier StateImmunologyFemalemedicine.symptombusinessEar, Nose & Throat Journal
researchProduct

Familial cases of boutonneuse fever

1987

Pairs of cases of Boutonneuse Fever (BF) occurred in three families. The illness appeared almost simultaneously in both members of each family, but was generally more serious in one as judged by clinical and laboratory parameters. The possibility of a "bed rickettsiosis", that is reactivation of rickettsiae by the blood meal obtained from the first individual by the same tick which fed upon the second individual, could be excluded in two of the three pairs of cases. In only one of the case pairs were the individuals sharing the same bed. The differences in severity of symptoms may be related to the different immunological pattern observed in these patients. Previous rickettsial infection ma…

AdultMalemedicine.medical_specialtyEpidemiologyTickBoutonneuse FeverAsymptomaticEpidemiologymedicineHumansAgedThiamphenicolbiologybusiness.industryMiddle Agedmedicine.diseasebiology.organism_classificationBoutonneuse feverRickettsiaRickettsiosisImmunoglobulin MImmunoglobulin GImmunologybiology.proteinFemalemedicine.symptomAntibodybusinessRickettsia conoriiEuropean Journal of Epidemiology
researchProduct

Cerebral abscesses imaging: A practical approach

2020

Abstract: Brain abscesses (BAs) are focal infections of the central nervous system (CNS) that start as a localised area of weakening of the brain parenchyma (cerebritis) and develops into a collection of pus surrounded by a capsule. Pyogenic (bacterial) BAs represent the majority of all BAs; in some cases, the diagnostic and therapeutic management can be challenging. Imaging has a primary role in differentiating BAs from other lesions. Conventional magnetic resonance imaging (cMRI) is essential for the identification of the lesion, its localisation and its morphological features. However, cMRI does not allow to reliably differentiate BAs from other intracranial mass lesions such as necrotic…

AdultMalemedicine.medical_specialtyFeverCerebral AbscesseseducationCentral nervous systemBrain Abscess030218 nuclear medicine & medical imagingDiagnosis DifferentialLesionYoung Adult03 medical and health sciences0302 clinical medicineMagnetic resonance spectroscopy (MRS)Brain absceBrain Injuries TraumaticParenchymamedicineHumansMagnetic resonance imaging (MRI)Brain abscessAgedDiffusion weighted imaging (DWI)medicine.diagnostic_testbusiness.industryPharmacology. TherapyHeadacheMagnetic resonance imagingMycobacterium tuberculosisMiddle Agedmedicine.diseaseMagnetic Resonance ImagingAspergillusmedicine.anatomical_structurePositron-Emission TomographyCerebritisFemaleRadiologyDifferential diagnosismedicine.symptombusinessToxoplasma030217 neurology & neurosurgeryJournal of Population Therapeutics & Clinical Pharmacology
researchProduct

[Correlation, in previously treated HIV-1 positive patients, between hypersensitivity reaction to abacavir and the presence of the HLA-B*5701 allele].

2009

Abstract Introduction Hypersensitivity reaction to abacavir (a powerful inverse transcriptase inhibitor) is a serious adverse effect that limits its use in antiretroviral treatment and requires a high level of clinical surveillance. Certain haplotypes of the primary histocompatibility complex proteins (HLA-B*5701) are very significant predictors of the risk of hypersensitivity to this drug. The purpose of this study is to identify the cases where a probable hypersensitivity reaction to abacavir presented the HLA-B*5701 allele. Method A retrospective study was conducted in all HIV-1 positive adult patients infected treated with abacavir between January 2000 and December 2007, in Department 6…

AdultMalemedicine.medical_specialtyFeverGenotypeAnti-HIV AgentsGastrointestinal DiseasesGenes MHC Class IHIV InfectionsPharmacotherapyAbacavirInternal medicineGenotypemedicineHumansGenetic Predisposition to DiseaseAdverse effectAgedRetrospective Studiesbusiness.industryRetrospective cohort studyMiddle AgedRashDideoxynucleosidesHypersensitivity reactionHLA-B AntigensImmunologyHIV-1Reverse Transcriptase InhibitorsFemaleDrug Eruptionsmedicine.symptombusinessPharmacogeneticsmedicine.drugFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
researchProduct

Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fl…

2005

The safety and efficacy of early bacterial prophylaxis with piperacillin-tazobactam were prospectively evaluated in 51 autologous peripheral blood stem cell transplantation (PBSCT) recipients. The results were compared with those obtained in 51 control patients receiving oral fluoroquinolones in a retrospective matched-pair control study. Overall, 76% of the study group and 98% of the control group developed at least one febrile episode during neutropenia (P=0.002). Time from neutropenia to the first febrile episode (FFE) was significantly longer in the study group than in the control group (P=0.04). Once a febrile episode appeared, the duration of fever was significantly longer in cases th…

AdultMalemedicine.medical_specialtyNeutropeniaAdolescentFevermedicine.drug_classMatched-Pair AnalysisPremedicationAntibioticsPenicillanic AcidBacteremiaGram-Positive BacteriaTazobactamTransplantation AutologousInternal medicineAmphotericin BGram-Negative Bacteriapolycyclic compoundsmedicineHumansAntibacterial agentAgedPiperacillinTransplantationPeripheral Blood Stem Cell TransplantationHematologybusiness.industryHematologyBacterial InfectionsMiddle AgedSurgeryPiperacillin Tazobactam Drug CombinationPiperacillin/tazobactamChemoprophylaxisFemaleStem cellbusinessPiperacillinmedicine.drugFluoroquinolonesBone marrow transplantation
researchProduct

Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patie…

1998

Extensive pretreatment has been identified as a significant risk factor for failure of sufficient PBSC mobilization. From published data and our own experience we defined pretreatment variables which render patients at risk for not collecting at least 2.5 x 10(6) CD34-positive cells per kg bodyweight (BW). These variables were previous unsuccessful PBSC mobilization trial, previous large field radiotherapy, four or more cycles of myelosuppressive chemotherapy regimens, and combinations of extended field radiotherapy plus chemotherapy. Based on these inclusion criteria we treated 19 patients with disease-specific conventional-dose chemotherapy followed by sequential subcutaneous administrati…

AdultMalemedicine.medical_specialtyNeutropeniaFevermedicine.medical_treatmentPainSalvage therapyGastroenterologyTesticular NeoplasmsRisk FactorsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactormedicineHumansMultiple myelomaTesticular cancerSalvage TherapyTransplantationMyelosuppressive ChemotherapyChemotherapybusiness.industryRemission InductionHematopoietic Stem Cell TransplantationDrug SynergismHematologyMiddle Agedmedicine.diseaseCombined Modality TherapyHematopoietic Stem Cell MobilizationBlood Cell CountSeminomaSurgeryGranulocyte colony-stimulating factorLymphomaRegimenHematologic NeoplasmsFemaleInterleukin-3GerminomabusinessBone Marrow Transplantation
researchProduct

Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropenia.

2002

Sepsis in chemotherapy-associated neutropenia is a major cause of mortality in the treatment of acute myeloid leukemia (AML). Early diagnosis of sepsis is crucial for patient survival. We analyzed the value of prospectively measuring serum concentrations of soluble tumor necrosis factor receptor type II (sTNF-RII) in patients with AML for early diagnosis of sepsis in neutropenia. Therefore, 54 adult patients with AML and neutropenia were followed around the onset of fever. A total of 59 febrile episodes were documented. We could not demonstrate a significant increase in sTNF-RII levels prior to fever. sTNF-RII concentrations were not predictive of the severity of a febrile episode. Based on…

AdultMalemedicine.medical_specialtyNeutropeniaTime FactorsFevermedicine.medical_treatmentPilot ProjectsNeutropeniaInfectionsGastroenterologySeverity of Illness IndexReceptors Tumor Necrosis FactorSepsisAntigens CDhemic and lymphatic diseasesInternal medicinemedicineHumansReceptors Tumor Necrosis Factor Type IIProspective StudiesAgedChemotherapyHematologyLeukopeniabusiness.industryOsmolar ConcentrationMyeloid leukemiaHematologyGeneral MedicineMiddle Agedmedicine.diseaseSolubilityLeukemia MyeloidImmunologyAcute DiseaseTumor necrosis factor alphaFemalemedicine.symptombusinessComplicationAnnals of hematology
researchProduct